Published in Am J Med Genet on July 12, 1996
Submicroscopic duplications of the hydroxysteroid dehydrogenase HSD17B10 and the E3 ubiquitin ligase HUWE1 are associated with mental retardation. Am J Hum Genet (2008) 1.80
Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders. Eur J Hum Genet (2015) 0.83
Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment. Schizophr Res (2008) 0.79
Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet (1998) 4.91
Fragile X genotype characterized by an unstable region of DNA. Science (1991) 4.33
Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet (2001) 3.83
Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet (1985) 3.42
Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature (1996) 3.21
Incidence and origin of "null" alleles in the (AC)n microsatellite markers. Am J Hum Genet (1993) 3.18
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (1995) 3.15
Role of transcription factors Brn-3.1 and Brn-3.2 in auditory and visual system development. Nature (1996) 2.81
PAK3 mutation in nonsyndromic X-linked mental retardation. Nat Genet (1998) 2.52
Northern venture. Can Med Assoc J (1966) 2.34
A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet (1997) 2.22
Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet (2001) 2.01
Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology (2004) 1.98
Fragile X syndrome: diagnosis using highly polymorphic microsatellite markers. Am J Hum Genet (1991) 1.95
Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet (1992) 1.91
Linkage studies with the gene for an X-linked syndrome of mental retardation, microcephaly and spastic diplegia (MRX2) Am J Med Genet (1988) 1.88
Role of the Bicoid-related homeodomain factor Pitx1 in specifying hindlimb morphogenesis and pituitary development. Genes Dev (1999) 1.88
Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet (1995) 1.86
Prenatal diagnosis of fragile X syndrome by direct detection of the unstable DNA sequence. N Engl J Med (1991) 1.83
Identification of the gene (SEDL) causing X-linked spondyloepiphyseal dysplasia tarda. Nat Genet (1999) 1.80
Development and survival of the endocrine hypothalamus and posterior pituitary gland requires the neuronal POU domain factor Brn-2. Genes Dev (1995) 1.78
Explanation for exclusive maternal origin for congenital form of myotonic dystrophy. Lancet (1993) 1.72
Genetic mapping of DNA segments relative to the locus for the fragile-X syndrome at Xq27.3. Am J Hum Genet (1985) 1.71
Mapping the short arm of human chromosome 16. Genomics (1989) 1.69
Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet (1996) 1.61
Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology (2003) 1.61
Genetic mapping of new RFLPs at Xq27-q28. Genomics (1991) 1.60
Fine mapping of gene probes and anonymous DNA fragments to the long arm of chromosome 16. Genomics (1988) 1.55
Somatic mutations in GLI3 can cause hypothalamic hamartoma and gelastic seizures. Neurology (2007) 1.44
Dinucleotide repeat polymorphisms at the D16S164, D16S168 and D16S186 loci at 16q21-q22.1. Nucleic Acids Res (1991) 1.42
Genetic mapping of new DNA probes at Xq27 defines a strategy for DNA studies in the fragile X syndrome. Am J Hum Genet (1991) 1.38
Labelling of potentially dangerous household products. Can Med Assoc J (1966) 1.38
The winged helix gene, Mf3, is required for normal development of the diencephalon and midbrain, postnatal growth and the milk-ejection reflex. Development (1997) 1.38
P-OTX: a PIT-1-interacting homeodomain factor expressed during anterior pituitary gland development. Proc Natl Acad Sci U S A (1996) 1.38
Cloning and characterization of the human activity-dependent neuroprotective protein. J Biol Chem (2001) 1.30
A non-syndromal form of X-linked mental retardation (XLMR) is linked to DXS14. Am J Med Genet (1988) 1.29
The Rubinstein-Taybi syndrome. Arch Dis Child (1968) 1.29
Allozyme genotype--environment relationships in natural populations of Drosophila buzzatii. Biochem Genet (1979) 1.27
Apnea and sudden unexpected death in infants with achondroplasia. J Pediatr (1984) 1.26
Bezoar: an unusual cause of protein-losing gastroenteropathy. Can Med Assoc J (1966) 1.26
Suggestion of a major gene for familial febrile convulsions mapping to 8q13-21. J Med Genet (1996) 1.26
A polygenic heterogeneity model for common epilepsies with complex genetics. Genes Brain Behav (2007) 1.25
De novo SCN1A mutations in migrating partial seizures of infancy. Neurology (2011) 1.23
Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B. Neurology (2002) 1.21
LGI1 mutations in temporal lobe epilepsies. Neurology (2004) 1.21
The Coffin-Lowry syndrome. Experience from four centres. Clin Genet (1982) 1.18
Genotype-phenotype relationships in fragile X syndrome: a family study. Am J Hum Genet (1993) 1.18
Cloverleaf skull and thanatophoric dwarfism. Report of four cases, two in the same sibship. Arch Dis Child (1971) 1.17
Reduced genetic load revealed by slow inbreeding in Drosophila melanogaster. Genetics (1995) 1.16
Fine genetic mapping of the Batten disease locus (CLN3) by haplotype analysis and demonstration of allelic association with chromosome 16p microsatellite loci. Genomics (1993) 1.16
X linked fatal infantile cardiomyopathy maps to Xq28 and is possibly allelic to Barth syndrome. J Med Genet (1995) 1.16
The heights and weights of Indian and Eskimo school children on James Bay and Hudson Bay. Can Med Assoc J (1969) 1.16
CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet (2000) 1.15
Becker muscular dystrophy (BMD) and Klinefelter's syndrome: a possible cause of variable expression of BMD within a pedigree. J Med Genet (1989) 1.12
The molecular basis of X-linked spondyloepiphyseal dysplasia tarda. Am J Hum Genet (2001) 1.12
Dinucleotide repeat polymorphism at D16S287. Nucleic Acids Res (1991) 1.11
Barth syndrome: clinical features and confirmation of gene localisation to distal Xq28. Am J Med Genet (1993) 1.11
How many X-linked genes for non-specific mental retardation (MRX) are there? Am J Med Genet (1996) 1.10
The fragile X syndrome II: preliminary data on growth and development in males. Am J Med Genet (1984) 1.09
Additional evidence for fragile X activity in heterozygous carriers. Am J Hum Genet (1983) 1.08
Determining the origin of human X isochromosomes by use of DNA sequence polymorphisms and detection of an apparent i(Xq) with Xp sequences. Hum Genet (1987) 1.08
Brief clinical report: the syndrome of Yunis and Varón--report of a further case. Am J Med Genet (1983) 1.07
Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann Neurol (1998) 1.05
Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. Genomics (1997) 1.05
Linkage and genetic counselling for the fragile X using DNA probes 52A, F9, DX13, and ST14. Am J Med Genet (1987) 1.05
Genetic adaptation to captivity and inbreeding depression in small laboratory populations of Drosophila melanogaster. Genetics (1995) 1.04
A new syndrome with mental retardation, short stature and an Xq duplication. Am J Med Genet (1988) 1.04
Gene structure and expression study of the SEDL gene for spondyloepiphyseal dysplasia tarda. Genomics (2000) 1.03
Generalized epilepsy with febrile seizures plus-associated sodium channel beta1 subunit mutations severely reduce beta subunit-mediated modulation of sodium channel function. Neuroscience (2007) 1.02
The relation between laboratory measures of sucking, food intake, and perinatal factors during the newborn period. Child Dev (1969) 1.02
Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation. Genomics (1999) 1.01
Novel mutations in the KCNQ2 gene link epilepsy to a dysfunction of the KCNQ2-calmodulin interaction. J Med Genet (2004) 1.01
Clinical and molecular genetics of myoclonic-astatic epilepsy and severe myoclonic epilepsy in infancy (Dravet syndrome). Brain Dev (2001) 1.00
Genes for intelligence on the X chromosome. J Med Genet (1991) 1.00
Assignment of the gene for central core disease to chromosome 19. Hum Genet (1990) 1.00
Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am J Hum Genet (1998) 1.00
Construction of a high-resolution linkage map for Xp22.1-p22.2 and refinement of the genetic localization of the Coffin-Lowry syndrome gene. Genomics (1994) 0.99
Tremor, ataxia and dementia in older men may indicate a carrier of the fragile X syndrome. Clin Genet (2003) 0.99
Claudins: unlocking the code to tight junction function during embryogenesis and in disease. Clin Genet (2010) 0.99
X-linked myoclonic epilepsy with spasticity and intellectual disability: mutation in the homeobox gene ARX. Neurology (2002) 0.99
Fragile X syndrome and fragile XE mental retardation. Prenat Diagn (1996) 0.98
Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures. J Med Genet (2007) 0.97
Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology (2006) 0.96
The Lesch-Nyhan syndrome: self-destructive biting, mental retardation, neurological disorder and hyperuricaemia. Dev Med Child Neurol (1967) 0.95
Familial cutaneous amyloidosis with systemic manifestations in males. Am J Med Genet (1981) 0.94
The fragile X syndrome I: familial variation in the proportion of lymphocytes with the fragile site in males. Am J Med Genet (1984) 0.94
A family with the Coffin Lowry syndrome revisited: localization of CLS to Xp21-pter. Am J Med Genet (1988) 0.94
Assignment of a gene (NEMI) for autosomal dominant nemaline myopathy to chromosome I. Am J Hum Genet (1992) 0.94
Case-finding in phenylketonuria: 3. One-way paper chromatography of amino acids in blood. Can Med Assoc J (1968) 0.94
Deafness due to Pro250Arg mutation of FGFR3. Lancet (1998) 0.93
A de novo mutation in sporadic nocturnal frontal lobe epilepsy. Ann Neurol (2000) 0.93
Powassan virus encephalitis in southeastern Ontario. Can Med Assoc J (1980) 0.93
The relation of plasma tyrosine level to weight gain of premature infants. J Pediatr (1966) 0.92
5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation. Dev Med Child Neurol (1972) 0.92
Identification of a highly polymorphic marker within intron 7 of the ALAS2 gene and suggestion of at least two loci for X-linked sideroblastic anemia. Hum Mol Genet (1992) 0.92
A linkage map of microsatellite markers on the human X chromosome. Genomics (1994) 0.92
Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: identification of a gene near FRAXE. Am J Hum Genet (1995) 0.92